Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
publishDate:"[2010 TO 2019]"
journalStr:"Annals of the rheumatic diseases"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&filter%5B%5D=journalStr%3A%22Annals+of+the+rheumatic+diseases%22&lookfor=%22Antibodies%2C+Monoclonal%2C+Humanized%22&type=Subject
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&filter%5B%5D=journalStr%3A%22Annals+of+the+rheumatic+diseases%22&lookfor=%22Antibodies%2C+Monoclonal%2C+Humanized%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&filter%5B%5D=journalStr%3A%22Annals+of+the+rheumatic+diseases%22&lookfor=%22Antibodies%2C+Monoclonal%2C+Humanized%22&type=Subject
PubPharm (346)
1
Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment
enthalten in:
Annals of the rheumatic diseases
| 2019
von
Lee, Y.
CommentOn: Ann Rheum Dis. 2018 Dec;77(12):1720-1729. - PMID 30279267
Wird geladen...
2
Response to : 'Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment' by Lee
enthalten in:
Annals of the rheumatic diseases
| 2019
von
Kaneko, Y.
|
Kameda, H.
|
Ikeda, K.
| +6
CommentOn: Ann Rheum Dis. 2018 Dec;77(12):1720-1729. - PMID 30279267
Wird geladen...
3
Response to : 'Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series' by Narváez
enthalten in:
Annals of the rheumatic diseases
| 2019
von
Khanna, D.
|
Jahreis, A.
|
Lin, C.
CommentOn: Ann Rheum Dis. 2018 Feb;77(2):212-220. - PMID 29066464
Wird geladen...
4
Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease : a case series
enthalten in:
Annals of the rheumatic diseases
| 2019
von
Narváez, J.
|
LLuch, J.
|
Alegre Sancho, J.
| +3
CommentOn: Ann Rheum Dis. 2018 Feb;77(2):212-220. - PMID 29066464
Wird geladen...
5
Immune checkpoint inhibitor rechallenge in patients with immune-related myositis
enthalten in:
Annals of the rheumatic diseases
| 2019
von
Delyon, J.
|
Brunet-Possenti, F.
|
Leonard-Louis, S.
| +6
Wird geladen...
6
Response to : 'Comment on: 'Lupus Low Disease Activity State(LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hocanalysis of the Phase IIb MUSE trial of anifrolumab' by Eric Morand et al' by Isenberg
enthalten in:
Annals of the rheumatic diseases
| 2019
von
Morand, E.
|
Trasieva, T.
|
Berglind, A.
| +2
CommentOn: Ann Rheum Dis. 2018 May;77(5):706-713. - PMID 29420200
Wird geladen...
7
Comment on : 'Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab' by Eric Morand et al
enthalten in:
Annals of the rheumatic diseases
| 2019
von
Isenberg, D.
CommentOn: Ann Rheum Dis. 2018 May;77(5):706-713. - PMID 29420200
Wird geladen...
8
Aortic ulceration in a tocilizumab-treated patient with Takayasu arteritis
enthalten in:
Annals of the rheumatic diseases
| 2019
von
Liebling, E.
|
Peterson, R.
|
Victoria, T.
| +1
CommentOn: Ann Rheum Dis. 2018 Mar;77(3):348-354. - PMID 29191819
Wird geladen...
9
Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis : an open-label, 18-month, prospective, pilot study
enthalten in:
Annals of the rheumatic diseases
| 2019
von
Nannini, C.
|
Niccoli, L.
|
Sestini, S.
| +3
CommentIn: Ann Rheum Dis. 2021 Nov;80(11):e184. - PMID 31690621
Wird geladen...
10
Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis : an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials
enthalten in:
Annals of the rheumatic diseases
| 2019
von
Verhoeven, M.
|
de Hair, M.
|
Tekstra, J.
| +10
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[35]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2010-2019
Filter aufheben
Zeitschrift: Annals of the rheumatic diseases
Medienart
346
Aufsätze
304
E-Artikel
304
E-Ressourcen
42
Gedruckte Aufsätze
Zeitschriftentitel
Annals of the rheumatic diseases
Thema
304
Antibodies, Monoclonal, Humanized
236
Journal Article
210
Antirheumatic Agents
196
Research Support, Non-U.S. Gov't
131
Antibodies, Monoclonal
118
Adalimumab
111
FYS6T7F842
110
Randomized Controlled Trial
96
Tumor Necrosis Factor-alpha
86
I031V2H011
86
tocilizumab
83
Multicenter Study
77
Methotrexate
73
YL5FZ2Y5U1
69
Rheumatoid Arthritis
67
Treatment
61
Letter
60
Immunoglobulin G
59
Receptors, Tumor Necrosis Factor
57
Etanercept
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2010-2019
31
2019
23
2018
24
2017
19
2016
85
2015
45
2014
43
2013
25
2012
32
2011
19
2010
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
346
Englisch
Haven't found what you're looking for?
Wird geladen...